Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,982
archived clinical trials in
Endocrine

Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
South Orange County Endocrinology
mi
from
Laguna Hills, CA
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
South Orange County Endocrinology
mi
from
Laguna Hills, CA
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Tower Urology
mi
from
Los Angeles, CA
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Tower Urology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
David Geffen School of Medicine
mi
from
Los Angeles, CA
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
David Geffen School of Medicine
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Harbor-UCLA Medical Center, LA Biomedical Research Institute
mi
from
Torrance, CA
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Harbor-UCLA Medical Center, LA Biomedical Research Institute
mi
from
Torrance, CA
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Connecticut Clinical Research Center/ConnecTrials
mi
from
Middlebury, CT
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Connecticut Clinical Research Center/ConnecTrials
mi
from
Middlebury, CT
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
University of CT School of Medicine
mi
from
New Haven, CT
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
University of CT School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
South Florida Medical Research
mi
from
Aventura, FL
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
South Florida Medical Research
mi
from
Aventura, FL
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
University of Louisville
mi
from
Louisville, KY
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins University
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Boston University School of Medicine
mi
from
Boston, MA
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Boston University School of Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Maimonides Medical Center
mi
from
Brooklyn, NY
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Maimonides Medical Center
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Bruce R. GIlbert, MD, PhD, PC
mi
from
Great Neck, NY
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Bruce R. GIlbert, MD, PhD, PC
mi
from
Great Neck, NY
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
University Urology Associates
mi
from
New York, NY
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
University Urology Associates
mi
from
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Michael A. Werner, MD PC
mi
from
Purchase, NY
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Michael A. Werner, MD PC
mi
from
Purchase, NY
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Sunstone Medical Research, LLC
mi
from
Medford, OR
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Sunstone Medical Research, LLC
mi
from
Medford, OR
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Research Across America
mi
from
Carrollton, TX
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Research Across America
mi
from
Carrollton, TX
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Research Across America
mi
from
Dallas, TX
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Research Across America
mi
from
Dallas, TX
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
University of Bonn, Clinic for Dermatology and Allergy
mi
from
Bonn,
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
University of Bonn, Clinic for Dermatology and Allergy
mi
from
Bonn,
Click here to add this to my saved trials
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated:  12/31/1969
Urologic Consultants of Southeast Pennsylvania
mi
from
Bala-Cynwyd, PA
Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Phase 3, Active-Controlled, Safety and Efficacy Trial of Oral Testosterone Undecanoate (TU) in Hypogonadal Men
Status: Enrolling
Updated: 12/31/1969
Urologic Consultants of Southeast Pennsylvania
mi
from
Bala-Cynwyd, PA
Click here to add this to my saved trials
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess The Pharmacokinetics And Pharmacodynamics Of Pf-04950615 Following Subcutaneous And Intravenous Doses In Adult Subjects With Hypercholesterolemia
Status: Enrolling
Updated:  12/31/1969
Profil Institute for Clinical Research
mi
from
Chula Vista, CA
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess The Pharmacokinetics And Pharmacodynamics Of Pf-04950615 Following Subcutaneous And Intravenous Doses In Adult Subjects With Hypercholesterolemia
Status: Enrolling
Updated: 12/31/1969
Profil Institute for Clinical Research
mi
from
Chula Vista, CA
Click here to add this to my saved trials
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess The Pharmacokinetics And Pharmacodynamics Of Pf-04950615 Following Subcutaneous And Intravenous Doses In Adult Subjects With Hypercholesterolemia
Status: Enrolling
Updated:  12/31/1969
Elite Research Institute
mi
from
Miami, FL
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess The Pharmacokinetics And Pharmacodynamics Of Pf-04950615 Following Subcutaneous And Intravenous Doses In Adult Subjects With Hypercholesterolemia
Status: Enrolling
Updated: 12/31/1969
Elite Research Institute
mi
from
Miami, FL
Click here to add this to my saved trials
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess The Pharmacokinetics And Pharmacodynamics Of Pf-04950615 Following Subcutaneous And Intravenous Doses In Adult Subjects With Hypercholesterolemia
Status: Enrolling
Updated:  12/31/1969
Vince and Associates Clinical Research
mi
from
Overland Park, KA
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess The Pharmacokinetics And Pharmacodynamics Of Pf-04950615 Following Subcutaneous And Intravenous Doses In Adult Subjects With Hypercholesterolemia
Status: Enrolling
Updated: 12/31/1969
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess The Pharmacokinetics And Pharmacodynamics Of Pf-04950615 Following Subcutaneous And Intravenous Doses In Adult Subjects With Hypercholesterolemia
Status: Enrolling
Updated:  12/31/1969
PAREXEL International - Baltimore Early Phase Clinical Unit
mi
from
Baltimore, MD
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess The Pharmacokinetics And Pharmacodynamics Of Pf-04950615 Following Subcutaneous And Intravenous Doses In Adult Subjects With Hypercholesterolemia
Status: Enrolling
Updated: 12/31/1969
PAREXEL International - Baltimore Early Phase Clinical Unit
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess The Pharmacokinetics And Pharmacodynamics Of Pf-04950615 Following Subcutaneous And Intravenous Doses In Adult Subjects With Hypercholesterolemia
Status: Enrolling
Updated:  12/31/1969
Jasper Clinic, Inc.
mi
from
Kalamazoo, MI
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess The Pharmacokinetics And Pharmacodynamics Of Pf-04950615 Following Subcutaneous And Intravenous Doses In Adult Subjects With Hypercholesterolemia
Status: Enrolling
Updated: 12/31/1969
Jasper Clinic, Inc.
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess The Pharmacokinetics And Pharmacodynamics Of Pf-04950615 Following Subcutaneous And Intravenous Doses In Adult Subjects With Hypercholesterolemia
Status: Enrolling
Updated:  12/31/1969
Prism Research Inc.
mi
from
Saint Paul, MN
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess The Pharmacokinetics And Pharmacodynamics Of Pf-04950615 Following Subcutaneous And Intravenous Doses In Adult Subjects With Hypercholesterolemia
Status: Enrolling
Updated: 12/31/1969
Prism Research Inc.
mi
from
Saint Paul, MN
Click here to add this to my saved trials
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess The Pharmacokinetics And Pharmacodynamics Of Pf-04950615 Following Subcutaneous And Intravenous Doses In Adult Subjects With Hypercholesterolemia
Status: Enrolling
Updated:  12/31/1969
Medpace Clinical Pharmacology Unit
mi
from
Cincinnati, OH
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
A Phase 1, Open-label, Randomized, Single Dose, Parallel Group Study To Assess The Pharmacokinetics And Pharmacodynamics Of Pf-04950615 Following Subcutaneous And Intravenous Doses In Adult Subjects With Hypercholesterolemia
Status: Enrolling
Updated: 12/31/1969
Medpace Clinical Pharmacology Unit
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
The Biodistribution of 18F-Clofarabine in Patients With Autoimmune and Inflammatory Diseases
Status: Enrolling
Updated:  12/31/1969
UCLA Jonsson Comprehensive Cancer Center
mi
from
Los Angeles, CA
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
The Biodistribution of 18F-Clofarabine in Patients With Autoimmune and Inflammatory Diseases
Status: Enrolling
Updated: 12/31/1969
UCLA Jonsson Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Vestibular Stimulation to Trigger Adipose Loss Clinical Trial
A Randomized, Double Blind Controlled Trial to Evaluate Efficacy of Vestibular Nerve Stimulation, Combined With a Lifestyle Modification Program, Compared to a Sham Control and Lifestyle Program, as a Means of Reducing Excess Body Weight.
Status: Enrolling
Updated:  12/31/1969
Altman Clinical and Translation Research Institute, UC San Diego
mi
from
San Diego, CA
Vestibular Stimulation to Trigger Adipose Loss Clinical Trial
A Randomized, Double Blind Controlled Trial to Evaluate Efficacy of Vestibular Nerve Stimulation, Combined With a Lifestyle Modification Program, Compared to a Sham Control and Lifestyle Program, as a Means of Reducing Excess Body Weight.
Status: Enrolling
Updated: 12/31/1969
Altman Clinical and Translation Research Institute, UC San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Ultrasound Elastography in Imaging Patients With Thyroid Nodules
Elastography in Thyroid Nodule Evaluation
Status: Enrolling
Updated:  12/31/1969
Stanford University School of Medicine
mi
from
Palo Alto, CA
Ultrasound Elastography in Imaging Patients With Thyroid Nodules
Elastography in Thyroid Nodule Evaluation
Status: Enrolling
Updated: 12/31/1969
Stanford University School of Medicine
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Exercise and Weight Loss for Improving Mobility in Older Adults Who Are Obese
Cooperative Lifestyle Intervention Program (CLIP)
Status: Enrolling
Updated:  12/31/1969
Guilford County, North Carolina Cooperative Extension Center
mi
from
Greensboro, NC
Exercise and Weight Loss for Improving Mobility in Older Adults Who Are Obese
Cooperative Lifestyle Intervention Program (CLIP)
Status: Enrolling
Updated: 12/31/1969
Guilford County, North Carolina Cooperative Extension Center
mi
from
Greensboro, NC
Click here to add this to my saved trials
Exercise and Weight Loss for Improving Mobility in Older Adults Who Are Obese
Cooperative Lifestyle Intervention Program (CLIP)
Status: Enrolling
Updated:  12/31/1969
Davidson County Coopertive Extension
mi
from
Lexington, NC
Exercise and Weight Loss for Improving Mobility in Older Adults Who Are Obese
Cooperative Lifestyle Intervention Program (CLIP)
Status: Enrolling
Updated: 12/31/1969
Davidson County Coopertive Extension
mi
from
Lexington, NC
Click here to add this to my saved trials
Exercise and Weight Loss for Improving Mobility in Older Adults Who Are Obese
Cooperative Lifestyle Intervention Program (CLIP)
Status: Enrolling
Updated:  12/31/1969
Forsyth County Cooperative Extension Center
mi
from
Winston-Salem, NC
Exercise and Weight Loss for Improving Mobility in Older Adults Who Are Obese
Cooperative Lifestyle Intervention Program (CLIP)
Status: Enrolling
Updated: 12/31/1969
Forsyth County Cooperative Extension Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease
Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease
Effect of a Modified Ketogenic-Mediterranean Diet on Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Wake Forest Baptist Health
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males
A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males
Status: Enrolling
Updated:  12/31/1969
California Clinical Trials
mi
from
Glendale, CA
A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males
A Phase 1/2a Study to Determine the Dose Response Pharmacokinetics of TSX-011 (Testosterone Undecanoate) in Hypogonadal Males
Status: Enrolling
Updated: 12/31/1969
California Clinical Trials
mi
from
Glendale, CA
Click here to add this to my saved trials
Impact of Pre-operative Steroids on Adrenal Insufficiency
Impact of Pre-operative Steroids on Adrenal Insufficiency and Clinical Outcomes After Neonatal Cardiac Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Impact of Pre-operative Steroids on Adrenal Insufficiency
Impact of Pre-operative Steroids on Adrenal Insufficiency and Clinical Outcomes After Neonatal Cardiac Surgery With Cardiopulmonary Bypass
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Chronic Cardiovascular Risk Outpatient Management in South Asians Using Digital Health Technology
Chronic Cardiovascular Risk Outpatient Management in South Asians Using Digital Health Technology
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Stanford, CA
Chronic Cardiovascular Risk Outpatient Management in South Asians Using Digital Health Technology
Chronic Cardiovascular Risk Outpatient Management in South Asians Using Digital Health Technology
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials
Clinical Trial of Growth Hormone in MPS I, II, and VI
Phase II/III, Randomized, Clinical Trial of the Effects of Nutropin AQ® on Growth and Bone Metabolism in Children With MPS I, II, and VI and Short Stature
Status: Enrolling
Updated:  12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Clinical Trial of Growth Hormone in MPS I, II, and VI
Phase II/III, Randomized, Clinical Trial of the Effects of Nutropin AQ® on Growth and Bone Metabolism in Children With MPS I, II, and VI and Short Stature
Status: Enrolling
Updated: 12/31/1969
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
The Effects of Prolonged Standing Compared to Prolonged Sitting on Postprandial Lipemia
The Effects of Prolonged Standing Compared to Prolonged Sitting on Postprandial Lipemia
Status: Enrolling
Updated:  12/31/1969
University of Texas at Austin Human Performance Laboratory
mi
from
Austin, TX
The Effects of Prolonged Standing Compared to Prolonged Sitting on Postprandial Lipemia
The Effects of Prolonged Standing Compared to Prolonged Sitting on Postprandial Lipemia
Status: Enrolling
Updated: 12/31/1969
University of Texas at Austin Human Performance Laboratory
mi
from
Austin, TX
Click here to add this to my saved trials
The Effect of Sitting and Moderate Exercise on Plasma Triglyceride Elevation After a Meal
The Effect of Sitting and Moderate Exercise on Plasma Triglyceride Elevation After a Meal
Status: Enrolling
Updated:  12/31/1969
University of Texas at Austin Human Performance Laboratory
mi
from
Austin, TX
The Effect of Sitting and Moderate Exercise on Plasma Triglyceride Elevation After a Meal
The Effect of Sitting and Moderate Exercise on Plasma Triglyceride Elevation After a Meal
Status: Enrolling
Updated: 12/31/1969
University of Texas at Austin Human Performance Laboratory
mi
from
Austin, TX
Click here to add this to my saved trials
Effects of Exercise and Energy Balance on 24-hour Blood Glucose Control
Effects of Exercise and Energy Balance on 24-hour Blood Glucose Control
Status: Enrolling
Updated:  12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Effects of Exercise and Energy Balance on 24-hour Blood Glucose Control
Effects of Exercise and Energy Balance on 24-hour Blood Glucose Control
Status: Enrolling
Updated: 12/31/1969
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness
Can Point-of-care Testing (POCT) and Assistance From Comprehensive Medication Management (CMM) Pharmacists Improve Early Detection and Management of Metabolic Syndrome in Patients Treated With Antipsychotic Medications?
Status: Enrolling
Updated:  12/31/1969
Family Life Mental Health Center
mi
from
Coon Rapids, MN
Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness
Can Point-of-care Testing (POCT) and Assistance From Comprehensive Medication Management (CMM) Pharmacists Improve Early Detection and Management of Metabolic Syndrome in Patients Treated With Antipsychotic Medications?
Status: Enrolling
Updated: 12/31/1969
Family Life Mental Health Center
mi
from
Coon Rapids, MN
Click here to add this to my saved trials
Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness
Can Point-of-care Testing (POCT) and Assistance From Comprehensive Medication Management (CMM) Pharmacists Improve Early Detection and Management of Metabolic Syndrome in Patients Treated With Antipsychotic Medications?
Status: Enrolling
Updated:  12/31/1969
Human Development Center
mi
from
Duluth, MN
Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness
Can Point-of-care Testing (POCT) and Assistance From Comprehensive Medication Management (CMM) Pharmacists Improve Early Detection and Management of Metabolic Syndrome in Patients Treated With Antipsychotic Medications?
Status: Enrolling
Updated: 12/31/1969
Human Development Center
mi
from
Duluth, MN
Click here to add this to my saved trials
Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness
Can Point-of-care Testing (POCT) and Assistance From Comprehensive Medication Management (CMM) Pharmacists Improve Early Detection and Management of Metabolic Syndrome in Patients Treated With Antipsychotic Medications?
Status: Enrolling
Updated:  12/31/1969
Range Mental Health Center
mi
from
Hibbing, MN
Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness
Can Point-of-care Testing (POCT) and Assistance From Comprehensive Medication Management (CMM) Pharmacists Improve Early Detection and Management of Metabolic Syndrome in Patients Treated With Antipsychotic Medications?
Status: Enrolling
Updated: 12/31/1969
Range Mental Health Center
mi
from
Hibbing, MN
Click here to add this to my saved trials
Prolonged Sitting on Responses to Short-Term Exercise Training
Effect of Prolonged Sitting on Metabolic and Cardiovascular Responses to Short-Term Exercise Training
Status: Enrolling
Updated:  12/31/1969
University of Texas at Austin Human Performance Laboratory
mi
from
Austin, TX
Prolonged Sitting on Responses to Short-Term Exercise Training
Effect of Prolonged Sitting on Metabolic and Cardiovascular Responses to Short-Term Exercise Training
Status: Enrolling
Updated: 12/31/1969
University of Texas at Austin Human Performance Laboratory
mi
from
Austin, TX
Click here to add this to my saved trials
"Clinical Evaluation of Opto-Acoustic Tomography for Detection and Diagnostic Differentiation of Thyroid Nodules"
"Clinical Evaluation of Opto-Acoustic Tomography for Detection and Diagnostic Differentiation of Thyroid Nodules"
Status: Enrolling
Updated:  12/31/1969
Invision Sally Jobe
mi
from
Greenwood Village, CO
"Clinical Evaluation of Opto-Acoustic Tomography for Detection and Diagnostic Differentiation of Thyroid Nodules"
"Clinical Evaluation of Opto-Acoustic Tomography for Detection and Diagnostic Differentiation of Thyroid Nodules"
Status: Enrolling
Updated: 12/31/1969
Invision Sally Jobe
mi
from
Greenwood Village, CO
Click here to add this to my saved trials
"Clinical Evaluation of Opto-Acoustic Tomography for Detection and Diagnostic Differentiation of Thyroid Nodules"
"Clinical Evaluation of Opto-Acoustic Tomography for Detection and Diagnostic Differentiation of Thyroid Nodules"
Status: Enrolling
Updated:  12/31/1969
UT Health and Science Center
mi
from
San Antonio, TX
"Clinical Evaluation of Opto-Acoustic Tomography for Detection and Diagnostic Differentiation of Thyroid Nodules"
"Clinical Evaluation of Opto-Acoustic Tomography for Detection and Diagnostic Differentiation of Thyroid Nodules"
Status: Enrolling
Updated: 12/31/1969
UT Health and Science Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Parallel Group Safety Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen® Administered Subcutaneously in Patients With Type 1 Diabetes Mellitus (T1DM)
Status: Enrolling
Updated:  12/31/1969
Compass Research LLC
mi
from
Orlando, FL
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Parallel Group Safety Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen® Administered Subcutaneously in Patients With Type 1 Diabetes Mellitus (T1DM)
Status: Enrolling
Updated: 12/31/1969
Compass Research LLC
mi
from
Orlando, FL
Click here to add this to my saved trials
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Parallel Group Safety Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen® Administered Subcutaneously in Patients With Type 1 Diabetes Mellitus (T1DM)
Status: Enrolling
Updated:  12/31/1969
Advanced Clinical Research, Inc.
mi
from
Meridian, ID
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Parallel Group Safety Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen® Administered Subcutaneously in Patients With Type 1 Diabetes Mellitus (T1DM)
Status: Enrolling
Updated: 12/31/1969
Advanced Clinical Research, Inc.
mi
from
Meridian, ID
Click here to add this to my saved trials
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Parallel Group Safety Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen® Administered Subcutaneously in Patients With Type 1 Diabetes Mellitus (T1DM)
Status: Enrolling
Updated:  12/31/1969
CRC - Clinical Research Center, Medizinische Universität Graz
mi
from
Graz,
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
A Phase 3, Randomized, Double-Blind, Parallel Group Safety Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen® Administered Subcutaneously in Patients With Type 1 Diabetes Mellitus (T1DM)
Status: Enrolling
Updated: 12/31/1969
CRC - Clinical Research Center, Medizinische Universität Graz
mi
from
Graz,
Click here to add this to my saved trials